A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/554 (2006.01) A61K 9/16 (2006.01) A61K 9/22 (2006.01) A61K 9/52 (2006.01)
Patent
CA 2307547
A controlled-release Galenical preparation of pharmaceutically acceptable Diltiazem including the pharmaceutically acceptable salts thereof, suitable for evening dosing every 24 hours containing from about 120 mg to about 540 mg or more (as desired) of the form of Diltiazem associated with excipients to provide controlled (sustained) release of the form of Diltiazem for providing a C max of Diltiazem in the blood at between about 10 hours and about 15 hours after administration, the preparation comprising the form of Diltiazem in oral sustained--release dosage form in which the Diltiazem is adapted to be released after administration over a prolonged period of time and exhibits when given to humans (i) a higher bioavailability when given at night compared to when given in the morning without food according to FDA guidelines or criteria and (ii) bioequivalence when given in the morning with and without food according to the same FDA guidelines or criteria.
Albert Kenneth Stephen
Maes Paul Jose
Albert Kenneth Stephen
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Biovail Laboratories International Srl
Maes Paul Jose
LandOfFree
Chronotherapeutic diltiazem formulations and the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chronotherapeutic diltiazem formulations and the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chronotherapeutic diltiazem formulations and the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1511919